Capsida Biotherapeutics has a total of 20 patents globally, out of which no patent have been granted. Of these 20 patents, more than 65% patents are active. Australia and Canada is where Capsida Biotherapeutics has filed the maximum number of patents, followed by Japan, United States of America and Europe. Parallelly, Canada seems to be the main focused R&D centre and also is the origin country of Capsida Biotherapeutics.
Capsida Biotherapeutics was founded in 2019. Capsida Biotherapeutics is a biotechnology company specializing in the development of precise gene therapies tailored for debilitating genetic disorders across central nervous system (CNS) and non-CNS conditions.
Do read about some of the most popular patents of Capsida Biotherapeutics which have been covered by us in this article and also you can find Capsida Biotherapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Capsida Biotherapeutics patent portfolio.
How many patents does Capsida Biotherapeutics have?
Capsida Biotherapeutics has a total of 20 patents globally. These patents belong to 13 unique patent families. Out of 20 patents, 13 patents are active.
How Many Patents did Capsida Biotherapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Capsida Biotherapeutics Applications Filed | Capsida Biotherapeutics Patents Granted |
| 2023 | 6 | – |
| 2022 | 7 | – |
| 2021 | 7 | – |
How many Capsida Biotherapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Capsida Biotherapeutics File in Different Countries?
Countries in which Capsida Biotherapeutics Filed Patents
| Country | Patent |
| Australia | 2 |
| Canada | 2 |
| Japan | 1 |
| United States of America | 1 |
| Europe | 1 |
Where are Research Centers of Capsida Biotherapeutics Patents Located?
The Research Centers of Capsida Biotherapeutics Patents is the United States of America.
List of Capsida Biotherapeutics patents
| Capsida Biotherapeutics Patents | Title |
| US20230303630A1 | Adeno-Associated Virus Compositions Having Preferred Expression Levels |
| EP4199972A2 | Adeno-Associated Virus Compositions Having Preferred Expression Levels |
| WO2023225508A3 | Selected Adeno-Associated Virus Compositions Having Preferred Brain, Spinal Cord, And/Or Heart Expression Levels |
| WO2023244920A2 | Adeno-Associated Virus Compositions Having Increased Brain Enrichment And/Or Heart Enrichment |
| WO2023244919A1 | Adeno-Associated Virus Compositions Having Increased Brain Enrichment And Decreased Liver Enrichment |
| WO2023183582A3 | Selected Aav Compositions Having Preferred Brain Enrichment |
| WO2023215546A2 | Adeno-Associated Virus Compositions Having Increased Brain Enrichment |
| WO2023183583A3 | Adeno-Associated Virus Compositions Having Increased Heart Enrichment |
| AU2022258447A1 | Aav Compositions Having High Expression Levels In Brain |
| AU2021329527A1 | Adeno-Associated Virus Compositions Having Preferred Expression Levels |
| CA3216172A1 | Aav Compositions Having High Expression Levels In Brain |
| CA3192600A1 | Adeno-Associated Virus Compositions Having Preferred Expression Levels |
| JP2023538129A | Adeno-Associated Virus Compositions With Favorable Expression Levels |
| WO2022221400A3 | Aav Compositions Having High Expression Levels In Brain |
| WO2022221420A3 | Selected Aav Compositions Having Preferred Brain Enrichment |
| WO2022221421A3 | Aav Compositions With High Brain Expression For Treating Mucopolysaccharidosis Ii |
| WO2022221404A3 | Adeno-Associated Virus Compositions Having Increased Brain Enrichment |
| WO2022221397A3 | Plasmids And Methods Of Production Of Adeno-Associated Viruses |
| WO2022040527A3 | Adeno-Associated Virus Compositions Having Preferred Expression Levels |
| WO2022040530A3 | Virus Compositions For Treating Mucopolysaccharidosis Ii |
What are Capsida Biotherapeutics key innovation segments?
What Technologies are Covered by Capsida Biotherapeutics?
The chart below distributes patents filed by Capsida Biotherapeutics